Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa-Reference-Cited by-同舟云学术

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

Published:2011-08-04 Issue:1 Volume:10 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Leach Amanda, ,Vekemans Johan,Lievens Marc,Ofori-Anyinam Opokua,Cahill Conor,Owusu-Agyei Seth,Abdulla Salim,Macete Eusebio,Njuguna Patricia,Savarese Barbara,Loucq Christian,Ballou W Ripley

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/1475-2875-10-224.pdf

Reference47 articles.

1. Breman JG, Alilio MS, White NJ: Defining and defeating the intolerable burden of malaria III. Progress and perspectives. Summary. Am J Trop Med Hyg. 2007, 77 (Suppl 6): vi-xi.

2. Anon: Rolling back malaria - the next 10 years. Lancet. 2008, 372: 1193-10.1016/S0140-6736(08)61494-4.

3. O'Meara WP, Mangeni JN, Steketee R, Greenwood B: Changes in the burden of malaria in sub-Saharan Africa. Lancet Inf Dis. 2010, 10: 545-555. 10.1016/S1473-3099(10)70096-7.

4. WHO: World Malaria Report. 2010

5. Carneiro I, Roca-Feltrer A, Griffin JT, Smith L, Tanner M, Schellenberg JA, Greenwood B, Schellenberg D: Age-Patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS ONE. 2010, 5: e8988-10.1371/journal.pone.0008988.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on malaria and dengue vaccines for the effective management of these mosquito borne diseases: Improving public health;Human Vaccines & Immunotherapeutics;2024-04-11

2. Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine;The Journal of Infectious Diseases;2024-03-04

3. Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data;PLOS ONE;2023-09-14

4. Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial;The Lancet Infectious Diseases;2022-09

5. Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection;Vaccine;2022-07